Compounds > captopril
Page last updated: 2024-08-23

captopril and Angiogenesis, Pathologic

captopril has been researched along with Angiogenesis, Pathologic in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (21.05)18.2507
2000's9 (47.37)29.6817
2010's5 (26.32)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Diz-Muñoz, A; Freire Valls, A; Imle, A; Liang, J; Lu, J; Muley, T; Radhakrishnan, P; Ruiz de Almodovar, C; Salfenmoser, M; Schleussner, N; Schmidt, T; Schneider, M; Shen, Y; Wang, G; Wang, X; Wirsik, NM1
Ager, EI; Christophi, C; Costa, PL; Koh, SL; Malcontenti-Wilson, C; Muralidharan, V1
Araújo, WF; Naves, MA; Ravanini, JN; Schor, N; Teixeira, VP1
Bolle, N; Fish, R; Kruithof, E; Pernod, G; Polack, B; Simard, B; Solly, F1
Al Sultan, MA; Al-Salam, S; Attoub, S; Gaben, AM; John, A; Mester, J; Nicholls, MG; Petroianu, G1
Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW1
Amore, C; Cugino, D; Cutrone, A; de Gaetano, G; Di Santo, A; Donati, MB; Iacoviello, L; Lorenzet, R; Napoleone, E1
Kunert-Radek, J; Lawnicka, H; Mucha, S; Pawlikowski, M; Ptasinska-Wnuk, D; Stepien, H1
Chan, B; Kale, S; Merchan, JR; Schnipper, LE; Sukhatme, VP1
Nasulewicz, A; Opolski, A1
de Groot-Besseling, RR; de Waal, RM; Poelen, GJ; Ruers, TJ; Ruiter, DJ; van Kraats, AA; Westphal, JR1
Mazur, A; Nasulewicz, A; Opolski, A1
Blann, AD; Caine, GJ; Christodoulos, K; Harris, AL; Lip, GY1
Baltogiannis, GG; Hatzistergos, KE; Kolettis, TM; Kyriakides, ZS; Malamou-Mitsi, V; Mitsi, AC; Niokou, D; Papalois, A; Pappa, L; Tsalikakis, DG1
Kleinman, HK; Lourdes Ponce, M1
Bouck, NP; Chesler, L; Johnson, MD; Lingen, MW; Molteni, A; Polverini, PJ; Solt, DB; Volpert, OV; Ward, WF1
Frey, FJ; Vogt, B1
Kalkman, EA; Saxena, PR; Schoemaker, RG; van Haren, P1
Hayashi, I; Ishihara, K; Kumagai, Y; Majima, M1

Reviews

3 review(s) available for captopril and Angiogenesis, Pathologic

ArticleYear
Captopril as a potential inhibitor of lung tumor growth and metastasis.
    Annals of the New York Academy of Sciences, 2008, Volume: 1138

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Captopril; Cell Division; Female; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1

2008
[The role of copper in tumor angiogenesis--clinical implications].
    Postepy higieny i medycyny doswiadczalnej, 2002, Volume: 56, Issue:6

    Topics: Animals; Captopril; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Trientine; Zinc

2002
Role of copper in tumour angiogenesis--clinical implications.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2004, Volume: 18, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Captopril; Chelating Agents; Clinical Trials as Topic; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Zinc

2004

Other Studies

16 other study(ies) available for captopril and Angiogenesis, Pathologic

ArticleYear
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
    Cancer cell, 2020, 06-08, Volume: 37, Issue:6

    Topics: Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bevacizumab; Cancer-Associated Fibroblasts; Captopril; Colorectal Neoplasms; Drug Synergism; Humans; Liver Neoplasms; Losartan; Lung Neoplasms; Neovascularization, Pathologic; Renin-Angiotensin System; Tumor Microenvironment

2020
Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
    Clinical & experimental metastasis, 2014, Volume: 31, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cell Proliferation; Colorectal Neoplasms; Immunoenzyme Techniques; Liver Neoplasms; Liver Regeneration; Male; Mice; Mice, Inbred CBA; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Burden; Tumor Cells, Cultured

2014
Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
    Urologic oncology, 2015, Volume: 33, Issue:9

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinoma, Renal Cell; Disease Models, Animal; Immunohistochemistry; Kidney Neoplasms; Losartan; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Renin-Angiotensin System

2015
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
    Cancer gene therapy, 2008, Volume: 15, Issue:10

    Topics: Angiostatins; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Cell Line, Tumor; Combined Modality Therapy; Genetic Therapy; Genetic Vectors; Glioma; Immunohistochemistry; Lentivirus; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Tissue Plasminogen Activator; Tumor Burden; Xenograft Model Antitumor Assays

2008
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    BMC cancer, 2011, Jun-26, Volume: 11

    Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A

2011
Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
    Thrombosis research, 2012, Volume: 129, Issue:6

    Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Breast Neoplasms; Captopril; Cell Line, Tumor; Down-Regulation; Enalapril; Female; Humans; MCF-7 Cells; Neovascularization, Pathologic; Renin-Angiotensin System; Thromboplastin; Vascular Endothelial Growth Factor A

2012
The involvement of angiotensin type 1 and type 2 receptors in estrogen-induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Animals; Captopril; Cell Proliferation; Diethylstilbestrol; Estrogens; Gene Expression Regulation; Hyperplasia; Imidazoles; Immunohistochemistry; Losartan; Male; Neovascularization, Pathologic; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A

2012
In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.
    Journal of the National Cancer Institute, 2003, Mar-05, Volume: 95, Issue:5

    Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Captopril; Cell Culture Techniques; Chromatography; Collagen; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Female; Humans; Laminin; Mice; Middle Aged; Neovascularization, Pathologic; Peptide Fragments; Plasma; Plasminogen; Plasminogen Activators; Precipitin Tests; Proteoglycans; Recombinant Proteins

2003
Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model.
    International journal of cancer, 2004, Nov-01, Volume: 112, Issue:2

    Topics: Angiogenesis Inhibitors; Angiostatins; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Melanoma; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Plasminogen Activators; Skin Neoplasms; Transplantation, Heterologous; Up-Regulation

2004
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
    Cancer letters, 2005, Mar-10, Volume: 219, Issue:2

    Topics: Adult; Aged; Angiogenesis Inhibitors; Anticoagulants; Captopril; Dalteparin; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; P-Selectin; Platelet Activation; Thromboplastin; Vascular Endothelial Growth Factor A

2005
Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction.
    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2006, Volume: 16, Issue:2

    Topics: Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Growth Hormone; Humans; Myocardial Infarction; Neovascularization, Pathologic; Swine; Ventricular Remodeling

2006
The good side of side effects: captopril blocks vessel and tumor growth.
    The Journal of clinical investigation, 1996, Aug-01, Volume: 98, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Neoplasms, Experimental; Neovascularization, Pathologic; Rats

1996
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
    The Journal of clinical investigation, 1996, Aug-01, Volume: 98, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Cell Movement; Endothelium, Vascular; Female; Metalloendopeptidases; Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Inbred F344

1996
Inhibition of angiogenesis in Kaposi's sarcoma by captopril.
    Lancet (London, England), 1997, Apr-19, Volume: 349, Issue:9059

    Topics: Captopril; Humans; Immune Tolerance; Kidney Transplantation; Male; Neovascularization, Pathologic; Postoperative Complications; Sarcoma, Kaposi

1997
Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis.
    European journal of pharmacology, 1999, Mar-26, Volume: 369, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Coronary Vessels; Lactates; Ligation; Male; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Purines; Rats; Rats, Wistar

1999
Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
    British journal of pharmacology, 2001, Volume: 133, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Bronchoconstriction; Capillary Permeability; Captopril; Edema; Guinea Pigs; Inflammation; Lung; Male; Mice; Mice, Inbred ICR; Molecular Mimicry; Neovascularization, Pathologic; Quinolines; Rats; Receptor, Bradykinin B2; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; Trachea

2001